Evidence map›Paper›PMID 33250632›Full record

ReviewAfrican journal of urology : the official journal of the Pan African Urological Surgeons' Association (PAUSA)2020

Urolithiasis treatment options during COVID-19 pandemic: review of current recommendations and triage systems.

Ali Abdel Raheem, Ibrahim Alowidah, Mohamed Soliman, Mefarrih Haresy, Ali Almozeni, Sultan Althagafi, Mohamed Almousa, Mohamed Alturki

Open access · diamondAbstract readReview
In one paragraph

Review in African journal of urology : the official journal of the Pan African Urological Surgeons' Association (PAUSA), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. COVID-19: The impact on urolithiasis treatment in Brazil.International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ali Abdel RaheemDepartment of Urology, Faculty of Medicine, Tanta University, Tanta, Egypt.ORCID 0000-0002-9294-2665
Ibrahim AlowidahDepartment of Urology, King Saud Medical City, Riyadh, Saudi Arabia.
Mohamed SolimanDepartment of Urology, Faculty of Medicine, Tanta University, Tanta, Egypt.
Mefarrih HaresyDepartment of Urology, King Saud Medical City, Riyadh, Saudi Arabia.
Ali AlmozeniDepartment of Urology, King Saud Medical City, Riyadh, Saudi Arabia.
Sultan AlthagafiDepartment of Urology, King Saud Medical City, Riyadh, Saudi Arabia.
Mohamed AlmousaDepartment of Urology, King Saud Medical City, Riyadh, Saudi Arabia.
Mohamed AlturkiDepartment of Urology, King Saud Medical City, Riyadh, Saudi Arabia.
King Saud Medical City · SATanta University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 pandemic has overwhelmed healthcare systems and limited access to surgical care. Urolithiasis can lead to emergencies and affect renal function during long-term follow-up. Therefore, timely and appropriate treatment is essential. MAIN TEXT: This is a non-systematic review of the recently published recommendations regarding urolithiasis treatment options during COVID-19. Fourteen publications were the basis of our review. Regarding anesthesia methods, the optimal methods are still unknown. During COVID-19, most of the endo-urologists changed their routine clinical practice and elective surgical treatment approaches. Despite decreasing number of emergency visits and admissions for stone disease, patients tend to have leukocytosis, higher creatinine levels, increased grade 3 and 4 hydronephrosis, and higher incidence of complications compared to non-COVID-19 time. Several alarming indications if present, intervention should be performed within 24 h to prevent irreversible kidney damage, disease progression, or even death. Some endo-urologists prefer definitive stone treatment over temporarily drainage to reduce the number of emergency room visits and hospital admissions, except if infection is present or staged treatment is planned. Several clinical scenarios of non-emergency and non-urgent urinary stones are present; thus, endo-urologists should appropriately weigh patient's risk and surgery benefit to decide to the proper intervention time. If risks outweighed benefits to the patient, postpone the surgery. Renal colic should be managed with medical expulsive therapy and proper pain control with close follow-up just in case it becomes an emergency. Indwelling JJ stent removal or exchange is a matter of debate; some endo-urologists recommend removing, while others recommend postponing.

conclusionTreatment options for urinary stones have markedly changed during COVID-19 pandemic. The optimal anesthesia methods are still unknown. Emergency intervention is a must if any alarming indications exist. Emergency cases tend to have higher incidence of complications compared to non-COVID-19 time. For non-emergency and non-urgent urolithiasis, endo-urologists should make judicious treatment decision to prioritize urolithiasis treatment, and they should weigh benefits and risks before surgery.

Indexed as

COVID-19PandemicRecommendationsUrolithiasis

Identifiers

PMID33250632
PMCPMC7685777
OpenAlexW3107631571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.